GHK-Cu (copper peptide) is a naturally occurring tripeptide bound to copper that declines with age and is studied for its role in collagen, elastin, and skin-repair signaling. It has become a fast-growing search term in skincare and biohacking discussion, though rigorous human trial data is thinner than the current level of popular interest.
Several specific statistics circulating on peptide-marketing sites for GHK-Cu — wrinkle-reduction and wound-closure percentages attributed to named recent trials — could not be traced to any real, indexed study despite direct searching. One frequently-cited paper (Watson et al. 2009) turns out, on direct verification, to be about an unspecified cosmetic product that doesn't name GHK-Cu at all. Only real, individually-verified findings are included below.
GHK-Cu is a naturally-occurring copper-binding tripeptide. Copper is a required building block for the enzyme that cross-links collagen and elastin into stable tissue — the mechanistic basis for its proposed repair effects.
Wound healing — animal studies (scald wounds): liposomal delivery increased blood-vessel-forming cell growth by 33.1%, boosted key wound-healing growth factors, and shortened healing time to 14 days. Wang et al., Wound Repair Regen, 2017
Ligament healing — animal studies (ACL reconstruction, n=72): produced measurably less joint looseness and better graft strength at 6 weeks vs. saline — but this benefit did not last: by 12 weeks, once treatment had stopped, no significant difference remained. Fu et al., J Orthop Res, 2015 A genuinely useful honest finding: a real effect, but one that faded once treatment stopped.
The one verified human trial found: comparing GHK-Cu vs. no GHK-Cu in post-laser skincare (n=13), blinded evaluators and computer analysis found no significant objective improvement in erythema or wrinkle/texture measures. The one significant finding was subjective — patients using GHK-Cu reported significantly higher satisfaction with perceived skin quality (P=0.04) despite the lack of objective difference. Miller et al., Arch Facial Plast Surg, 2006
This is the entire verified human evidence base found for GHK-Cu — one small trial with a null objective result and a positive subjective one. That's a meaningfully weaker human evidence position than several other compounds in this category.
Animal (intra-articular, ligament model): 0.3 or 3mg/mL, weekly injections. Human (topical, the one verified trial): exact concentration not specified in the available abstract. No injectable/subcutaneous human dosing trial was found.
The one real human RCT wasn't designed as a dedicated safety study — it was a cosmetic-outcome trial, and reported no notable adverse findings. No dedicated toxicity/safety study was found for GHK-Cu specifically — a genuine gap, not an implied clean safety record.
Most commonly discussed for skin firmness, collagen support, and general anti-aging research, both topically and as an injectable in research contexts.
There is real, if limited, human evidence — including an older University of Toronto study showing measurable improvements in skin firmness and fine lines after topical use — but it is far less studied than the current wave of online interest implies.
That evidence is almost entirely about the topical form; injectable GHK-Cu leans on animal data and community reports rather than published human trials.
No, for either form. Topical copper-peptide products are regulated as cosmetics, not drugs, so they were never in approval territory to begin with.
The injectable research form got a notable update in April 2026 though: the FDA removed it from its 'significant safety risk' compounding list. That's a meaningfully positive signal, but it's a separate step from being approved — a full review of its longer-term compounding status is still ahead, expected by early 2027.
Yes — GHK-Cu is short for glycyl-histidyl-lysine, a naturally occurring tripeptide that binds tightly to copper. That copper binding is basically the whole story: it's what gives the peptide its signature blue color and most of its biological activity.
There are really two different products under one name. The copper peptide in a skincare serum is topical, made for your skin.
Injectable GHK-Cu is a separate research compound aimed at effects beyond the skin — think joints, gut, general tissue repair — with its own dosing and its own, much newer, evidence base.
For skin-level effects, yes — and honestly, that's the better-studied way to use it. Injectable GHK-Cu is chasing something different: systemic effects a serum sitting on your skin simply can't reach.
The copper. When it's bound correctly inside the peptide, the resulting complex reflects blue light, so a nice blue or turquoise color is actually a good sign.
If a batch looks pale or clear, that usually means the copper has come loose and the peptide has degraded.
There's a genuine mechanism behind the idea — it stimulates the cells at the base of hair follicles and improves blood flow around them.
But the human evidence is still thin and mostly small-scale, and it's not an approved hair-loss treatment anywhere. In theory it works best on follicles that are struggling, not ones that are already gone.
Same core ingredient, very different product. Drugstore serums are formulated and dosed for topical skin use, with real clinical trials behind them.
What's listed here in injectable form is a research compound with a different delivery method, different dosing, and a much newer evidence base.
It has a plausible mechanism for it — anti-inflammatory action plus collagen remodeling — which is why people research it for scar tissue.
It's not a guaranteed fix, and once tissue is fully scarred over, no peptide undoes that. It seems most promising earlier, while tissue is still actively remodeling.
Through the vetted suppliers we compare right here — that's the whole point of this site. We show you who carries it, at what price, with what delivery options, so you're not digging through forums to find a real source.
Looking for something specific, or placing a wholesale order? Send us a DM or email.